ICTM logo
STAMPEDE shortlisted for the BMJ UK Research Paper of the Year award

09 May 2018

STAMPEDE has been shortlisted for the BMJ UK Research Paper of the Year award for the second year in a row; the first to be shortlisted twice for different papers.

Now in their 10th year, The BMJ Awards are the UK's leading medical awards. They promote excellence in healthcare and recognise the inspirational work of healthcare teams across the country.

This coveted award recognises original research that has the potential to contribute significantly to improving health and health care.

MRC CTU at UCL has previously featured at the awards, with wins for ARROW (2014) and FEAST (2012), and nominations for STAMPEDE and QUARTZ (both 2017). A huge amount of work goes on within hospitals and the central coordinating centre across the length of a trial. The nomination is a timely reminder of the nature of these large collaborative projects, which typically run over many years.

The shortlisted paper is titled 'Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.'

"Abiraterone not only prolonged life, but also lowered the relative chance of relapse and reduced the relative chance of serious bone complications." said STAMPEDE Chief Investigator Nicholas James, Professor of Clinical Oncology at Queen Elizabeth Hospital in Birmingham.

The STAMPEDE trial aims to prevent prostate cancer tumour re-growth by adding other treatment(s) to hormone therapy. STAMPEDE is the largest ever prostate cancer treatment trial, having already recruited over 10,000 men.

Mahesh Parmar, Director of the MRC Clinical Trials Unit at UCL, said: "STAMPEDE has pioneered the multi-arm, multi-stage platform randomised trial design and will answer 11 major questions over 20 years. This is decades faster than answering these questions in any other way. The STAMPEDE design has been adopted in other cancers, infectious diseases and plans are being developed to apply it to key neuro-degenerative diseases, such as Alzheimer's disease where we have no active treatments for this disease."

The BMJ Awards will be held on Thursday 10 May 2018, at the Park Plaza Westminster.